Latest news with #KingFaisalSpecialistHospitalandResearchCentre
Leaders
15-05-2025
- Health
- Leaders
KFSHRC, Cleveland Clinic Partner to Enhance Autism, Neurosciences Care
King Faisal Specialist Hospital and Research Centre (KFSHRC) has entered into a strategic partnership with Cleveland Clinic, a leading non-profit academic medical center, to collaborate on clinical, operational, educational, and research initiatives in the fields of autism and neurosciences. This collaboration underscores KFSHRC's commitment to advancing medical innovation and excellence through international partnerships. The Memorandum of Understanding (MoU) was signed at KFSHRC's Riyadh headquarters by Dr. Majid Alfayyadh, CEO of KFSHRC, and Dr. Tomislav Mihaljevic, CEO and President of Cleveland Clinic. Moreover, it sets the foundation for a long-term collaboration aimed at enhancing specialized care through joint project teams that will evaluate and prioritize areas for cooperation. This initiative is expected to strengthen KFSHRC's role as a regional leader in neuroscience and autism care. This partnership aligns with KFSHRC's broader mission to foster impactful global collaborations that promote knowledge exchange and capacity building. It also supports the goals of Saudi Arabia's Health Sector Transformation Program, part of Vision 2030, which focuses on expanding access to high-quality, preventive healthcare services. Related Topics: Media Minister Praises KFSHRC Team for World's 1st Fully Robotic Heart Transplant KFSHRC Shines: Saudi Medical Talent Impresses at Global Competition Pope's Final Wish: Transforming Popemobile into Health Clinic for Gaza Children SFDA Introduces 3 New Regulations to Foster Healthy Community Nutrition Short link : Post Views: 44 Related Stories
Mid East Info
07-05-2025
- Health
- Mid East Info
One-Stop Breast Tumour Diagnosis : KFSHRC Pioneers Same-Visit Biopsy
Riyadh The King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully implemented an advanced interventional technique for diagnosing breast tumours that are undetectable by conventional imaging methods. This innovation enables physicians to obtain precise biopsy samples during the same visit, thereby accelerating the diagnostic process and initiating earlier treatment. This shift in diagnostic approach addresses cases recorded in recent years where certain breast abnormalities could only be identified through contrast-enhanced imaging. Consequently, the hospital has adopted Contrast-Enhanced Mammography (CEM) as a precise clinical tool to overcome these diagnostic challenges. Previously, the standard protocol necessitated scheduling a separate MRI-guided biopsy following initial imaging, often leading to redundant procedures, increased patient burden, higher healthcare costs, and delayed treatment initiation. In contrast, the new CEM-guided approach facilitates immediate and accurate tissue sampling during the same imaging session, eliminating the need for additional appointments. KFSHRC brings substantial expertise to this advanced modality, having been the first to introduce contrast-enhanced mammography in the Kingdom nearly a decade ago. It remains one of the select healthcare centres in the Middle East that routinely employs this technique in clinical settings, reinforcing its diagnostic ecosystem and expediting treatment decisions with enhanced precision. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Zawya
16-04-2025
- Health
- Zawya
KFSHRC receives Italy's Health Minister, highlights medical advancements
Riyadh: King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh received H.E. Orazio Schillaci, Italy's Minister of Health, during an official visit aimed at exploring key areas of medical excellence and learning more about Saudi Arabia's experience in advancing specialized healthcare services. H.E. was welcomed by Dr. Björn Zoëga, Deputy Chief Executive Officer of KFSHRC. The visit featured a comprehensive briefing on the Heart Centre of Excellence and the Organ Transplant Centre of Excellence, along with an overview of the latest technologies used in treating complex cardiac conditions and performing minimally invasive robotic surgeries. These innovations have significantly reduced complications, accelerated recovery, and lowered healthcare costs. This visit reflects the growing global interest in KFSHRC's pioneering model, which integrates deep clinical expertise with cutting-edge medical technologies. The hospital has achieved several historic milestones, including the world's first fully robotic heart transplant and the first fully robotic liver transplant. These breakthroughs reinforce its standing as a global reference in advanced specialized care. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@
Zawya
15-04-2025
- Health
- Zawya
KFSHRC treats artery blockage with innovative non-surgical technique
Riyadh: King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully treated several patients suffering from below-the-knee peripheral artery stenosis and occlusion using an innovative, minimally invasive technique. The procedure involves inserting a next-generation bioresorbable stent through a fine catheter in the thigh, eliminating the need for open surgery. This approach restored blood flow to the limbs, relieved pain, accelerated the healing of chronic wounds, and significantly reduced the risk of amputation. With this achievement, KFSHRC has become the first center in the Kingdom, and the third worldwide outside the United States to adopt this advanced treatment method. The advanced technique, successfully implemented at KFSHRC in Riyadh and Jeddah, uses a bioresorbable stent inserted into narrowed or blocked vessels to temporarily restore blood flow. After serving its purpose, the stent dissolves naturally, eliminating the need for a permanent implant and lowering the risk of future complications. This minimally invasive approach also speeds up recovery and improves leg circulation, allowing patients to regain mobility more effectively. Peripheral artery stenosis and occlusion restrict blood flow to the legs, causing pain while walking, poor circulation, and chronic ulcers that are slow to heal. In advanced stages, the condition can progress to critical limb ischemia, increasing the risk of amputation. Although treatments like balloon angioplasty exist, below-the-knee arteries remain difficult to treat due to their substantial risk of re-narrowing, underscoring the need for more advanced solutions. The success of this procedure was driven by the Interventional Radiology Department at KFSHRC in Riyadh and Jeddah, in collaboration with the Vascular Surgery departments and nursing teams, demonstrating KFSHRC's commitment to integrated patient care. Building on this achievement, KFSHRC aims to expand research on this technique and collaborate with global medical institutions to evaluate its long-term effectiveness, contributing to the development of new treatment protocols for peripheral vascular diseases. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit contact our media team at mediacoverage@
Mid East Info
24-03-2025
- Health
- Mid East Info
Under the Patronage of the Minister of Health, KFSHRC Wins Three Awards at the National Patient Safety Award Ceremony 2024
Under the esteemed patronage and presence of His Excellency Fahad Al-Jalajel, Minister of Health, King Faisal Specialist Hospital and Research Centre (KFSHRC) has been honored with three prestigious awards at the seventh edition of the National Patient Safety Award, presented by the Saudi Patient Safety Center, recognizing its unwavering commitment to enhancing patient safety and elevating the quality of healthcare through pioneering initiatives. KFSHRC received the Choosing Wisely Track Award for its initiative, 'Enhancing Patient Engagement and Safety through a Modified Breast Clinical Pathway', which empowers patients to take an active role in their treatment journey while strengthening medical safety protocols. In addition, KFSHRC secured the Mentorship Track Award for its initiative, 'Strategic Management and Oversight Approach for Patient Safety Improvement: Optimizing Project Implementation and outcomes ', underscoring its leadership in implementing hospital-wide safety strategies that drive excellence in patient care. KFSHRC also received General Patient Safety Track Award for its initiative, 'Decrease the Number of CAUTI Cases in Acute Care Admission Unit', which has significantly improved patient outcomes and minimized the need for additional medical interventions. These accolades reaffirm KFSHRC's dedication to the highest standards of patient safety and its role as a leader in pioneering healthcare advancements. The hospital remains committed to delivering world-class specialized medical care, in alignment with its vision to be the preferred healthcare destination for patients seeking excellence. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
